ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.216,19
1,54%
S&P 500
5.975,38
0,55%
Dow Jones
42.706,56
-0,06%
Euro vs US Dollar
1,03831
0,00%
Bitcoin
102.003,15
-0,28%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Selvita Sa (0RKT) Börsenkurse

Selvita Sa

Selvita Sa (0RKT)

LSE
57,00
0,00
(0,00%)
Geschlossen 07 Januar 5:30PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
57,00
Gebot
0,00
Fragen
0,00
Volumen
0,00
0,00 Tagesbereich 0,00
57,00 52-Wochen-Bereich 57,00
Marktkapitalisierung
1,318B
Handelsende
57,00
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1
Ausgegebene Aktien
23.120.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-14,31
Gewinn pro Aktie (EPS)
-3,98
Erlöse
67,99M
Nettogewinn
-92,11M

Über Selvita Sa

Sektor
Chemicals & Chem Preps, Nec
Branche
Chemicals & Chem Preps, Nec
Website
ryvu.com
Hauptsitz
Krakow, Pol
Gegründet
-
Selvita Sa is listed in the Chemicals & Chem Preps sector of the Londoner Börse with ticker 0RKT. The last closing price for Selvita was PLN57,00. Over the last year, Selvita shares have traded in a share price range of PLN 57,00 to PLN 57,00.

Selvita currently has 23.120.000 shares in issue. The market capitalisation of Selvita is PLN1,32 billion. Selvita has a price to earnings ratio (PE ratio) of -14.31.

0RKT Neueste Nachrichten

Weitere Nachrichten

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 23, 2024...

23 Oktober 2024
PR Newswire (US)

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 9, 2024...

09 Oktober 2024
PR Newswire (US)

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit PR Newswire KRAKOW, Poland, Sept. 23, 2024 ONCO Prime is a cutting-edge drug discovery...

23 September 2024
PR Newswire (US)

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress PR Newswire KRAKOW, Poland, June 14, 2024 RVU120 as a single agent showed...

14 Juni 2024
PR Newswire (US)

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting PR Newswire KRAKOW, Poland, March 6, 2024 Updated preclinical data will be...

06 März 2024
UK Regulatory

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS PR Newswire KRAKOW...

14 Februar 2024
UK Regulatory

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting PR Newswire KRAKOW, Poland, Nov. 2, 2023 Updated data from the Phase I trial of RVU120...

02 November 2023
PR Newswire (US)

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update PR Newswire KRAKOW, Poland, Sept. 28, 2022 KRAKOW, Poland, Sept. 28, 2022 /PRNewswire/ -- Ryvu...

28 September 2022
PR Newswire (US)

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress PR Newswire KRAKOW, Poland, June 10, 2022 - Clinically...

10 Juni 2022
PR Newswire (US)

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting PR Newswire KRAKOW, Poland, March 8, 2022 KRAKOW, Poland, March 8, 2022 /PRNewswire/ -- Ryvu Therapeutics...

08 März 2022
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10057575700DE
400575757457DE
1200575757157DE
2600575757157DE
5200575757057DE
15600575757057DE
26000575757057DE

0RKT - Frequently Asked Questions (FAQ)

What is the current Selvita share price?
The current share price of Selvita is PLN 57,00
How many Selvita shares are in issue?
Selvita has 23.120.000 shares in issue
What is the market cap of Selvita?
The market capitalisation of Selvita is PLN 1,32B
What is the 1 year trading range for Selvita share price?
Selvita has traded in the range of PLN 57,00 to PLN 57,00 during the past year
What is the PE ratio of Selvita?
The price to earnings ratio of Selvita is -14,31
What is the cash to sales ratio of Selvita?
The cash to sales ratio of Selvita is 19,38
What is the reporting currency for Selvita?
Selvita reports financial results in PLN
What is the latest annual turnover for Selvita?
The latest annual turnover of Selvita is PLN 67,99M
What is the latest annual profit for Selvita?
The latest annual profit of Selvita is PLN -92,11M
What is the registered address of Selvita?
The registered address for Selvita is ST. LEONA HENRYKA STERNBACHA 2, KRAKOW, 30-394
What is the Selvita website address?
The website address for Selvita is ryvu.com
Which industry sector does Selvita operate in?
Selvita operates in the CHEMICALS & CHEM PREPS, NEC sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SCGLSealand Capital Galaxy Limited
3,25p
(103,13%)
12,18M
BORBorders & Southern Petroleum Plc
3,64p
(51,04%)
23,81M
NEONeo Energy Metals Plc
0,95p
(22,58%)
37,84M
GNIPGenip Plc
32,00p
(20,75%)
192,82k
ZIOCZanaga Iron Ore Company Limited
10,50p
(19,86%)
2,84M
DGIDg Innovate Plc
0,02p
(-20,00%)
298,54M
SNGSynairgen Plc
2,10p
(-19,39%)
1,67M
VRSVersarien Plc
0,03p
(-18,92%)
103,72M
QEDQuadrise Plc
5,90p
(-17,83%)
17,66M
ZENZenith Energy Ltd.
4,90p
(-16,24%)
1,48M
SYMESupply@me Capital Plc
0,0042p
(12,00%)
1,19B
MSMNMosman Oil And Gas Limited
0,035p
(12,90%)
654,48M
TRPTower Resources Plc
0,0395p
(0,00%)
570,56M
CPXCap-xx Limited
0,1775p
(-2,74%)
379,2M
NTVONativo Resources Plc
0,0019p
(-5,00%)
312,89M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
0RKT
Selvita
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten